Antibody Drug Conjugates: Nonclinical Safety Considerations

Overview of attention for article published in The AAPS Journal, May 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 1 X user

patent: 5 patents

Citations

dimensions_citation: 83 Dimensions

Readers on

mendeley: 133 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 5 patents that reference this research output.

Method for producing antibody-drug conjugate

Grant US-11945882-B2

United States of America

Anti-GPR20 antibody and anti-GPR20 antibody-drug conjugate

Grant US-11434289-B2

United States of America

Method for producing antibody-drug conjugate

Grant US-11318212-B2

United States of America

Glycan-interacting compounds and methods of use

Grant US-11028181-B2

United States of America

Anti-GPR20 antibody and anti-GPR20 antibody-drug conjugate

Grant US-10906974-B2

United States of America